Clazosentan in Preventing the Occurrence of Cerebral Vasospasm Following an Aneurysmal Subarachnoid Hemorrhage (aSAH)
Status:
Completed
Trial end date:
2006-03-30
Target enrollment:
Participant gender:
Summary
The purpose of the study is to measure how effective and safe three different doses of the
drug clazosentan are in preventing vasospasm after subarachnoid hemorrhage.